Walbert Timothy P 4

What Happened
Timothy P. Walbert, a director of BioMarin Pharmaceutical Inc. (BMRN), was granted 7,490 restricted stock units (RSUs) on June 2, 2026. The Form 4 reports an acquisition price of $0 for the award, which is typical for RSU grants (no cash purchase). This was a grant/award transaction (code A), not a purchase or sale.

Key Details

• Transaction date: June 2, 2026; Form 4 filed June 4, 2026 (appears timely — filed two business days after the transaction).
• Transaction type/code: Award/Grant (A).
• Amount: 7,490 restricted stock units; reported acquisition price $0 (price not applicable for RSUs).
• Shares owned after transaction: Not specified in the provided filing data.
• Footnote: F1 — "Restricted stock units granted on June 2, 2026. Price not applicable."
• Accession: 0001628280-26-040920 (SEC filing reference).

Context
RSUs are a form of equity compensation that typically vest over time or upon meeting service/performance conditions; they do not represent an immediate open-market purchase or sale. Grants to directors are common as part of compensation and do not, by themselves, indicate buying or selling sentiment. The Form 4 shows the grant but does not state vesting terms or the director’s total holdings; consult company proxy statements or subsequent filings for vesting schedules and fuller ownership context.